Johnsons Baby First Touch Gift Set

Zinc Oxide


Johnson & Johnson Consumer Inc.
Human Otc Drug
NDC 58232-9915
Johnsons Baby First Touch Gift Set also known as Zinc Oxide is a human otc drug labeled by 'Johnson & Johnson Consumer Inc.'. National Drug Code (NDC) number for Johnsons Baby First Touch Gift Set is 58232-9915. This drug is available in dosage form of Kit. The names of the active, medicinal ingredients in Johnsons Baby First Touch Gift Set drug includes . The currest status of Johnsons Baby First Touch Gift Set drug is Active.

Drug Information:

Drug NDC: 58232-9915
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Johnsons Baby First Touch Gift Set
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Zinc Oxide
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Johnson & Johnson Consumer Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Kit
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 07 Jul, 2015
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 01 Dec, 2023
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part347
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 24 Dec, 2025
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Johnson & Johnson Consumer Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:349404
1090577
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
58232-9915-91 KIT in 1 CONTAINER (58232-9915-9) * 266 mL in 1 BOTTLE * 207 mL in 1 BOTTLE * 266 mL in 1 BOTTLE * 1 TUBE in 1 CARTON (58232-0723-3) / 56 g in 1 TUBE07 Jul, 201501 Dec, 2023No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose skin protectant

Product Elements:

Johnsons baby first touch gift set zinc oxide desitin rapid relief creamy fragrance free zinc oxide water mineral oil petrolatum yellow wax dimethicone sorbitan sesquioleate microcrystalline wax peg-30 dipolyhydroxystearate (4000 mw) magnesium sulfate, unspecified form phenoxyethanol methylparaben potassium hydroxide propylparaben .alpha.-tocopherol acetate aloe vera leaf zinc oxide zinc oxide johnsons baby water isopropyl palmitate glycerin stearic acid glyceryl monostearate cetyl alcohol cetostearyl alcohol dimethicone mineral oil phenoxyethanol polysorbate 20 magnesium aluminum silicate p-anisic acid sodium hydroxide xanthan gum ethylhexylglycerin pentaerythritol tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate) d&c red no. 33 johnsons baby water peg-80 sorbitan laurate cocamidopropyl betaine sodium trideceth sulfate peg-150 distearate phenoxyethanol glycerin citric acid monohydrate sodium benzoate edetate sodium ethylhexylglycerin sodium hydroxide fd&c yellow no. 6 d&c yellow no. 10 johnsons baby head-to-toe wash water cocamidopropyl betaine peg-80 sorbitan laurate sodium trideceth sulfate peg-150 distearate glycerin edetate sodium citric acid monohydrate sodium hydroxide sodium benzoate ethylhexylglycerin phenoxyethanol

Indications and Usage:

Uses helps treat and prevent diaper rash protects chafed skin due to diaper rash and helps seal out wetness

Warnings:

Warnings for external use only. when using this product do not get into eyes stop use and ask a doctor if condition worsens symptoms last more than 7 days or clear up and occur again within a few days keep out of reach of children . if swallowed, get medical help or contact a poison control center right away.

When Using:

When using this product do not get into eyes

Dosage and Administration:

Directions change wet and soiled diapers promptly cleanse the diaper area allow to dry apply cream liberally as often as necessary, with each diaper change, especially at bedtime or anytime when exposure to wet diapers may be prolonged

Stop Use:

Stop use and ask a doctor if condition worsens symptoms last more than 7 days or clear up and occur again within a few days

Package Label Principal Display Panel:

Principal display panel - kit carton johnson's ® baby first touch ® gift set juego de regalo primer cuidado™ your gift contains: johnson's ® baby shampoo – 7 fl oz (207 ml) ● johnson's ® baby head-to-toe ® wash – 9 fl oz (266 ml) ● johnson's ® baby lotion – 9 fl oz (266 ml) ● desitin ® rapid relief zinc oxide diaper rash cream – 2 oz (56 g) ● 1 bath caddy principal display panel - kit carton

Further Questions:

Questions? call toll-free 800-720-3843 or 215-273-8755 (collect)


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.